115 related articles for article (PubMed ID: 37131597)
1. Allogeneic Tumor Cell-Derived Extracellular Vesicles Stimulate CD8 T Cell Response in Colorectal Cancer.
Gates TJ; Wangmo D; Zhao X; Subramanian S
bioRxiv; 2023 Apr; ():. PubMed ID: 37131597
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic tumor cell-derived extracellular vesicles stimulate CD8 TÂ cell response in colorectal cancer.
Gates TJ; Wangmo D; Zhao X; Subramanian S
Mol Ther Oncolytics; 2023 Dec; 31():100727. PubMed ID: 37822487
[TBL] [Abstract][Full Text] [Related]
3. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses.
Zhao X; Yuan C; Wangmo D; Subramanian S
Gastroenterology; 2021 Aug; 161(2):560-574.e11. PubMed ID: 33895168
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy.
Prakash A; Gates T; Zhao X; Wangmo D; Subramanian S
Pharmacol Ther; 2023 Jan; 241():108332. PubMed ID: 36526013
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory role of tumor-derived extracellular vesicles in colorectal cancer.
Manning S; Danielson KM
Immunol Cell Biol; 2018 Mar; ():. PubMed ID: 29575270
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M
Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV inhibits colorectal cancer metastasis by reducing extracellular vesicles release and suppressing M2-type TAMs activation.
Zhou J; Li L; Pu Y; Li H; Wu X; Wang Z; Sun J; Song Q; Zhou L; Ma X; Yang L; Ji Q
Heliyon; 2024 May; 10(10):e31450. PubMed ID: 38831823
[TBL] [Abstract][Full Text] [Related]
9. Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity.
Ortiz-Bonilla CJ; Uccello TP; Gerber SA; Lord EM; Messing EM; Lee YF
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328324
[TBL] [Abstract][Full Text] [Related]
10. Fruquintinib Enhances the Antitumor Immune Responses of Anti-Programmed Death Receptor-1 in Colorectal Cancer.
Li Q; Cheng X; Zhou C; Tang Y; Li F; Zhang B; Huang T; Wang J; Tu S
Front Oncol; 2022; 12():841977. PubMed ID: 35371995
[TBL] [Abstract][Full Text] [Related]
11. Novel antitumor therapeutic strategy using CD4
Shin S; Jung I; Jung D; Kim CS; Kang SM; Ryu S; Choi SJ; Noh S; Jeong J; Lee BY; Park JK; Shin J; Cho H; Heo JI; Jeong Y; Choi SH; Lee SY; Baek MC; Yea K
Biomaterials; 2022 Oct; 289():121765. PubMed ID: 36067566
[TBL] [Abstract][Full Text] [Related]
12. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
13. Role of kynurenine in promoting the generation of exhausted CD8
Wu D; Zhu Y
Am J Transl Res; 2021; 13(3):1535-1547. PubMed ID: 33841677
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-activated (AAA) CD4
Mochizuki K; Kobayashi S; Takahashi N; Sugimoto K; Sano H; Ohara Y; Mineishi S; Zhang Y; Kikuta A
J Exp Clin Cancer Res; 2021 Oct; 40(1):314. PubMed ID: 34625113
[TBL] [Abstract][Full Text] [Related]
16. Development of CD40L-modified tumor small extracellular vesicles for effective induction of antitumor immune response.
Liu W; Takahashi Y; Morishita M; Nishikawa M; Takakura Y
Nanomedicine (Lond); 2020 Jul; 15(17):1641-1652. PubMed ID: 32664826
[No Abstract] [Full Text] [Related]
17. Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype.
Kobayashi S; Kondo N; Tomiyama T; Nakamura N; Masuda M; Matsumoto Y; Honzawa Y; Tahara T; Ikeura T; Fukui T; Okazaki K; Naganuma M
Cancer Immunol Immunother; 2023 Nov; 72(11):3651-3664. PubMed ID: 37597014
[TBL] [Abstract][Full Text] [Related]
18. B7-H5 blockade enhances CD8
Wang J; Wu H; Chen Y; Zhu J; Sun L; Li J; Yao Z; Chen Y; Zhang X; Xia S; Chen W; Shi T
Cell Death Discov; 2021 Sep; 7(1):248. PubMed ID: 34537815
[TBL] [Abstract][Full Text] [Related]
19. The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche.
Blavier L; Nakata R; Neviani P; Sharma K; Shimada H; Benedicto A; Matei I; Lyden D; DeClerck YA
J Extracell Vesicles; 2023 May; 12(5):e12326. PubMed ID: 37194998
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles-derived microRNA-222 promotes immune escape via interacting with ATF3 to regulate AKT1 transcription in colorectal cancer.
Li S; Yan G; Yue M; Wang L
BMC Cancer; 2021 Apr; 21(1):349. PubMed ID: 33794833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
